Cargando…

The epidemic of malignant mesothelioma in China: a prediction of incidence during 2016–2030

BACKGROUND: Malignant mesothelioma is an invasive cancer with a poor prognosis. The crude incidence rate of malignant mesothelioma in China increased throughout 2000 to 2013, which attracted attention. In order to predict the incidence trend of malignant mesothelioma in China, a Bayesian age-period-...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhai, Yirui, Hui, Zhouguang, Chen, Wanqing, Ying, Jianming, Li, Junling, Gao, Shugeng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: AME Publishing Company 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9830266/
https://www.ncbi.nlm.nih.gov/pubmed/36636406
http://dx.doi.org/10.21037/tlcr-22-233
_version_ 1784867632870064128
author Zhai, Yirui
Hui, Zhouguang
Chen, Wanqing
Ying, Jianming
Li, Junling
Gao, Shugeng
author_facet Zhai, Yirui
Hui, Zhouguang
Chen, Wanqing
Ying, Jianming
Li, Junling
Gao, Shugeng
author_sort Zhai, Yirui
collection PubMed
description BACKGROUND: Malignant mesothelioma is an invasive cancer with a poor prognosis. The crude incidence rate of malignant mesothelioma in China increased throughout 2000 to 2013, which attracted attention. In order to predict the incidence trend of malignant mesothelioma in China, a Bayesian age-period-cohort (APC) prediction model was constructed using publicly available data from the National Cancer Registration Network. METHODS: Based on the annual reports of the national cancer registration from 2005 to 2015, the incidence trend of malignant mesothelioma from 2016 to 2030 in China was forecast using the APC Modeling and Prediction package from the Institute of Biomedical Engineering, London. RESULTS: The crude incidence rates of malignant mesothelioma decreased from 2.2 per one million person-years in 2005 to 1.6 per one million person-years in 2015. The incidence rates remained stable over the 11-year time period after age standardization. Aging was found to have a dominant effect on the trends. The Bayesian APC model showed that the crude incidence rates would increase from 1.4 per one million person-years in 2016 to 1.9 per one million person-years in 2030, and the estimated number of new incident cases would increase to 2,775 in 2030. The age-standardized incidence rate (ASR) remained steady. CONCLUSIONS: In the future decade, the incidence of malignant mesothelioma may increase, but the ASR will remain stable. Considering its high degree of malignancy, malignant mesothelioma still needs to be taken seriously.
format Online
Article
Text
id pubmed-9830266
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher AME Publishing Company
record_format MEDLINE/PubMed
spelling pubmed-98302662023-01-11 The epidemic of malignant mesothelioma in China: a prediction of incidence during 2016–2030 Zhai, Yirui Hui, Zhouguang Chen, Wanqing Ying, Jianming Li, Junling Gao, Shugeng Transl Lung Cancer Res Original Article BACKGROUND: Malignant mesothelioma is an invasive cancer with a poor prognosis. The crude incidence rate of malignant mesothelioma in China increased throughout 2000 to 2013, which attracted attention. In order to predict the incidence trend of malignant mesothelioma in China, a Bayesian age-period-cohort (APC) prediction model was constructed using publicly available data from the National Cancer Registration Network. METHODS: Based on the annual reports of the national cancer registration from 2005 to 2015, the incidence trend of malignant mesothelioma from 2016 to 2030 in China was forecast using the APC Modeling and Prediction package from the Institute of Biomedical Engineering, London. RESULTS: The crude incidence rates of malignant mesothelioma decreased from 2.2 per one million person-years in 2005 to 1.6 per one million person-years in 2015. The incidence rates remained stable over the 11-year time period after age standardization. Aging was found to have a dominant effect on the trends. The Bayesian APC model showed that the crude incidence rates would increase from 1.4 per one million person-years in 2016 to 1.9 per one million person-years in 2030, and the estimated number of new incident cases would increase to 2,775 in 2030. The age-standardized incidence rate (ASR) remained steady. CONCLUSIONS: In the future decade, the incidence of malignant mesothelioma may increase, but the ASR will remain stable. Considering its high degree of malignancy, malignant mesothelioma still needs to be taken seriously. AME Publishing Company 2022-12 /pmc/articles/PMC9830266/ /pubmed/36636406 http://dx.doi.org/10.21037/tlcr-22-233 Text en 2022 Translational Lung Cancer Research. All rights reserved. https://creativecommons.org/licenses/by-nc-nd/4.0/Open Access Statement: This is an Open Access article distributed in accordance with the Creative Commons Attribution-NonCommercial-NoDerivs 4.0 International License (CC BY-NC-ND 4.0), which permits the non-commercial replication and distribution of the article with the strict proviso that no changes or edits are made and the original work is properly cited (including links to both the formal publication through the relevant DOI and the license). See: https://creativecommons.org/licenses/by-nc-nd/4.0 (https://creativecommons.org/licenses/by-nc-nd/4.0/) .
spellingShingle Original Article
Zhai, Yirui
Hui, Zhouguang
Chen, Wanqing
Ying, Jianming
Li, Junling
Gao, Shugeng
The epidemic of malignant mesothelioma in China: a prediction of incidence during 2016–2030
title The epidemic of malignant mesothelioma in China: a prediction of incidence during 2016–2030
title_full The epidemic of malignant mesothelioma in China: a prediction of incidence during 2016–2030
title_fullStr The epidemic of malignant mesothelioma in China: a prediction of incidence during 2016–2030
title_full_unstemmed The epidemic of malignant mesothelioma in China: a prediction of incidence during 2016–2030
title_short The epidemic of malignant mesothelioma in China: a prediction of incidence during 2016–2030
title_sort epidemic of malignant mesothelioma in china: a prediction of incidence during 2016–2030
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9830266/
https://www.ncbi.nlm.nih.gov/pubmed/36636406
http://dx.doi.org/10.21037/tlcr-22-233
work_keys_str_mv AT zhaiyirui theepidemicofmalignantmesotheliomainchinaapredictionofincidenceduring20162030
AT huizhouguang theepidemicofmalignantmesotheliomainchinaapredictionofincidenceduring20162030
AT chenwanqing theepidemicofmalignantmesotheliomainchinaapredictionofincidenceduring20162030
AT yingjianming theepidemicofmalignantmesotheliomainchinaapredictionofincidenceduring20162030
AT lijunling theepidemicofmalignantmesotheliomainchinaapredictionofincidenceduring20162030
AT gaoshugeng theepidemicofmalignantmesotheliomainchinaapredictionofincidenceduring20162030
AT zhaiyirui epidemicofmalignantmesotheliomainchinaapredictionofincidenceduring20162030
AT huizhouguang epidemicofmalignantmesotheliomainchinaapredictionofincidenceduring20162030
AT chenwanqing epidemicofmalignantmesotheliomainchinaapredictionofincidenceduring20162030
AT yingjianming epidemicofmalignantmesotheliomainchinaapredictionofincidenceduring20162030
AT lijunling epidemicofmalignantmesotheliomainchinaapredictionofincidenceduring20162030
AT gaoshugeng epidemicofmalignantmesotheliomainchinaapredictionofincidenceduring20162030